- United States
- /
- Building
- /
- OTCPK:MKUL.Q
Molekule Group Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
Molekule Group (NASDAQ:MKUL) Second Quarter 2023 Results
Key Financial Results
- Revenue: US$13.2m (up by US$13.2m from 2Q 2022).
- Net loss: US$25.0m (loss widened by 383% from 2Q 2022).
- US$0.76 loss per share (further deteriorated from US$0.37 loss in 2Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Molekule Group Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) missed analyst estimates significantly.
The company's shares are down 33% from a week ago.
Risk Analysis
We should say that we've discovered 5 warning signs for Molekule Group (4 are potentially serious!) that you should be aware of before investing here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OTCPK:MKUL.Q
Molekule Group
Molekule Group, Inc., an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities.
Slightly overvalued with worrying balance sheet.
Market Insights
Weekly Picks

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fiducian: Compliance Clouds or Value Opportunity?
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Recently Updated Narratives

ADNOC Gas future shines with a 21.4% revenue surge
Watch Pulse Seismic Outperform with 13.6% Revenue Growth in the Coming Years
Significantly undervalued gold explorer in Timmins, finally getting traction
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
